Last updated: July 05, 2026

Application No. 18/569,169

A NON-THERAPEUTIC COSMETIC METHOD FOR REDUCING WRINKLES ON A SKIN SURFACE

Non-Final OA

Filed

Dec 11, 2023

Priority

Jul 16, 2021 — JP 2021-117999 +2 more

Examiner

MILLER, DALE R

Art Unit

1693

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

L'Oréal S.A.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +17.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 719 resolved cases, 2023–2026

Examiner Intelligence

MILLER, DALE R View full profile →

Grants 62% of resolved cases

Career Allowance Rate

448 granted / 719 resolved

+2.3% vs TC avg

Strong +17% interview lift

Without

With

+17.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

30 currently pending

Career history

747

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

63.1%

+23.1% vs TC avg

§102

7.4%

-32.6% vs TC avg

§112

4.7%

-35.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 719 resolved cases

Prosecution Timeline

Dec 11, 2023

Application Filed

Apr 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/920,720

Patent 12661366

OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING VIRAL INFECTIONS

3y 8m to grant Granted Jun 23, 2026

17/498,200

Patent 12642810

Edible Energy Composition

4y 7m to grant Granted Jun 02, 2026

18/245,658

Patent 12642814

TOPICAL ANTIVIRAL COMPOSITIONS COMPRISING HYALURONIC ACID AND CARRAGEENAN

3y 2m to grant Granted Jun 02, 2026

17/787,854

Patent 12636298

COMPOSITION

3y 11m to grant Granted May 26, 2026

18/033,866

Patent 12622863

INJECTABLE COMPOSITION AND USE OF SAID COMPOSITION

3y 0m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

79%

With Interview (+17.1%)

2y 7m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 719 resolved cases by this examiner. Grant probability derived from career allowance rate.